Table 6. Proportion of variance in total cost explained, by diagnosis-related group (DRG) splits, staging splits, and general linear model.
Adjacent DRG | Number of cases | DRG splits | Staging splits | Analytical model | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
||||||
R2 | R2 | R2 | F-values and significance | |||||
| ||||||||
Condition | Stage by condition | Unrelated comorbidity | Age | |||||
Biliary tract procedures | 1265 | .07 | .11 | .19 | 43.60* | 16.27* | 46.14* | 14.89* |
Cirrhosis and alcoholic hepatitis | 299 | 10 | .16 | .18 | 2.38 | 12.62* | 0.03 | 1.27 |
Diabetes mellitus | 2290 | .0001 | .08 | .09 | 10 | 45.44* | 66.10* | 2.15 |
Benign prostatic hypertrophy | 370 | .02 | .11 | .14 | 10 | 10.85* | 27.29* | 1.78 |
Insufficient degrees of freedom for this effect.
Significant at the 5-percent level.